Cargando…

CDCA5, Transcribed by E2F1, Promotes Oncogenesis by Enhancing Cell Proliferation and Inhibiting Apoptosis via the AKT Pathway in Hepatocellular Carcinoma

Cell division cycle associated 5 (CDCA5) is an important element for the interaction between cohesin and chromatin in interphase. It is abnormally expressed in many types of cancer and works as an indicator of poor prognosis, but little is known about its activity in hepatocellular carcinoma (HCC)....

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Hao, Chen, Jun, Zhao, Long, Song, Wenfeng, Xuan, Zefeng, Chen, Jian, Li, Zequn, Song, Guangyuan, Hong, Liangjie, Song, Penghong, Zheng, Shusen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547986/ https://www.ncbi.nlm.nih.gov/pubmed/31205541 http://dx.doi.org/10.7150/jca.28809

Ejemplares similares

Hypermethylation of GNA14 and its tumor-suppressive role in hepatitis B virus-related hepatocellular carcinoma
por: Song, Guangyuan, et al.
Publicado: (2021)

A novel role for farnesoid X receptor in the bile acid‐mediated intestinal glucose homeostasis
por: Zhao, Long, et al.
Publicado: (2020)

Inhibiting the NF-κB pathway enhances the antitumor effect of cabazitaxel by downregulating Bcl-2 in pancreatic cancer
por: Li, Zequn, et al.
Publicado: (2020)

How DNA methylation affects the Warburg effect
por: Zhu, Xingxin, et al.
Publicado: (2020)

Culture of patient-derived multicellular clusters in suspended hydrogel capsules for pre-clinical personalized drug screening
por: Dong, Haijiang, et al.
Publicado: (2022)

FXR Maintains the Intestinal Barrier and Stemness by Regulating CYP11A1-Mediated Corticosterone Synthesis in Biliary Obstruction Diseases
por: Li, Zequn, et al.
Publicado: (2023)

Knockdown of CDCA8 inhibits the proliferation and enhances the apoptosis of bladder cancer cells
por: Gao, Xin, et al.
Publicado: (2020)

Management of intrahepatic splenosis:a case report and review of the literature
por: Xuan, Zefeng, et al.
Publicado: (2018)

Splenic marginal zone lymphoma: a case report and literature review
por: Zhang, Shiyu, et al.
Publicado: (2020)

KCa3.1 as an Effective Target for Inhibition of Growth and Progression of Intrahepatic Cholangiocarcinoma
por: Song, Penghong, et al.
Publicado: (2017)

CDCA5 regulates proliferation in hepatocellular carcinoma and has potential as a negative prognostic marker
por: Shen, Zhiqing, et al.
Publicado: (2018)

E2F4 Promotes the Proliferation of Hepatocellular Carcinoma Cells through Upregulation of CDCA3
por: Liu, Junye, et al.
Publicado: (2021)

Antihypertension Nanoblockers Increase Intratumoral Perfusion of Sequential Cytotoxic Nanoparticles to Enhance Chemotherapy Efficacy against Pancreatic Cancer
por: Bian, Suchen, et al.
Publicado: (2022)

Distinct expression of CDCA3, CDCA5, and CDCA8 leads to shorter relapse free survival in breast cancer patient
por: Phan, Nam Nhut, et al.
Publicado: (2018)

Sox15 Methylation Inhibits Cell Proliferation Through Wnt Signaling in Hepatocellular Carcinoma
por: Wei, Bajin, et al.
Publicado: (2022)

CDCA8 induced by NF-YA promotes hepatocellular carcinoma progression by regulating the MEK/ERK pathway
por: Chen, Erbao, et al.
Publicado: (2023)

CDCA2 promotes the proliferation of colorectal cancer cells by activating the AKT/CCND1 pathway in vitro and in vivo
por: Feng, Yifei, et al.
Publicado: (2019)

CDCA8 expression and its clinical relevance in patients with bladder cancer
por: Bi, Yaqiong, et al.
Publicado: (2018)

CDCA3 Is a Novel Prognostic Biomarker Associated with Immune Infiltration in Hepatocellular Carcinoma
por: Wang, Zhihuai, et al.
Publicado: (2021)

USP22 mediates the multidrug resistance of hepatocellular carcinoma via the SIRT1/AKT/MRP1 signaling pathway
por: Ling, Sunbin, et al.
Publicado: (2017)

KIF22 promotes bladder cancer progression by activating the expression of CDCA3
por: Li, Kai, et al.
Publicado: (2021)

Silencing CDCA8 Suppresses Hepatocellular Carcinoma Growth and Stemness via Restoration of ATF3 Tumor Suppressor and Inactivation of AKT/β–Catenin Signaling
por: Jeon, Taewon, et al.
Publicado: (2021)

Identification of CDCA2 as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma
por: Yu, Zhenjun, et al.
Publicado: (2021)

The role of the CDCA gene family in ovarian cancer
por: Chen, Chongxiang, et al.
Publicado: (2020)

Function and Expression of Cystic Fibrosis Transmembrane Conductance Regulator after Small Intestinal Transplantation in Mice
por: Song, Penghong, et al.
Publicado: (2013)

[Retracted] KIF22 promotes bladder cancer progression by activating the expression of CDCA3
por: Li, Kai, et al.
Publicado: (2023)

CDCA2 Promotes HCC Cells Development via AKT–mTOR Pathway
por: Li, Kai, et al.
Publicado: (2022)

CDCA2 Inhibits Apoptosis and Promotes Cell Proliferation in Prostate Cancer and Is Directly Regulated by HIF-1α Pathway
por: Zhang, Yixiang, et al.
Publicado: (2020)

CDCA2 acts as an oncogene and induces proliferation of clear cell renal cell carcinoma cells
por: Li, Fang, et al.
Publicado: (2020)

Circular RNA hsa_circ_101555 promotes hepatocellular carcinoma cell proliferation and migration by sponging miR-145-5p and regulating CDCA3 expression
por: Gu, Xiaoguang, et al.
Publicado: (2021)

CDCA4 interacts with IGF2BP1 to regulate lung adenocarcinoma proliferation via the PI3K/AKT pathway
por: Feng, Sitong, et al.
Publicado: (2023)

CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC)
por: Tian, Yunhong, et al.
Publicado: (2018)

The inhibitory effect of silencing CDCA3 on migration and proliferation in bladder urothelial carcinoma
por: Shen, Dexin, et al.
Publicado: (2021)

As a downstream target of the AKT pathway, NPTX1 inhibits proliferation and promotes apoptosis in hepatocellular carcinoma
por: Zhao, Yue, et al.
Publicado: (2019)

SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT pathway
por: Luo, Zhenzhen, et al.
Publicado: (2021)

TMED3 promotes the development of malignant melanoma by targeting CDCA8 and regulating PI3K/Akt pathway
por: Guo, Xianling, et al.
Publicado: (2023)

Synonymous mutations in oncogenesis and apoptosis versus survival unveiled by network modeling
por: Li, Xiang, et al.
Publicado: (2016)

CDCA5 functions as a tumor promoter in bladder cancer by dysregulating mitochondria-mediated apoptosis, cell cycle regulation and PI3k/AKT/mTOR pathway activation
por: Fu, Guanghou, et al.
Publicado: (2020)

CDCA8/SNAI2 Complex Activates CD44 to Promote Proliferation and Invasion of Pancreatic Ductal Adenocarcinoma
por: Gu, Jichun, et al.
Publicado: (2022)

CDCA3 mediates p21-dependent proliferation by regulating E2F1 expression in colorectal cancer
por: Qian, Wenwei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ep226nh5fouiuif81kij6mcors